Bates PC

References (3)

Title : Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes - Ristic_2006_Drugs.Today.(Barc)_42_519
Author(s) : Ristic S , Bates PC
Ref : Drugs Today (Barc) , 42 :519 , 2006
Abstract :
PubMedSearch : Ristic_2006_Drugs.Today.(Barc)_42_519
PubMedID: 16969429

Title : Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes - Ristic_2006_Drugs.Today.(Barc)_42_519
Author(s) : Ristic S , Bates PC
Ref : Drugs Today (Barc) , 42 :519 , 2006
Abstract :
PubMedSearch : Ristic_2006_Drugs.Today.(Barc)_42_519
PubMedID: 16969429

Title : Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes - Ristic_2006_Drugs.Today.(Barc)_42_519
Author(s) : Ristic S , Bates PC
Ref : Drugs Today (Barc) , 42 :519 , 2006
Abstract :
PubMedSearch : Ristic_2006_Drugs.Today.(Barc)_42_519
PubMedID: 16969429